Fluconazole Versus Micafungin in Neonates With Candidiasis
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine whether micafungin is as efficacious as the current
standard of fluconazole, to compare the safety of the two drugs in the treatment of proven
neonatal candidiasis.
It is also designed to further elucidate the pharmacokinetics of the two products in the
growing and developing neonate and premature infant.